SectorPharmaceutical
Established Date17/04/2018
Listing Date16/07/2021
ExchangeNASDAQ Stock Exchange
Full-time Employees142
Fiscal Year Ends31/12
Security TypeCommon stock
Office address830 Winter Street, Waltham, Massachusetts 02451
Business
IntroductionTScan Therapeutics, Inc., was incorporated in Delaware on April 17, 2018. The company is a preclinical stage biopharmaceutical company focused on developing powerful T cell receptor engineered T cells or TCR-T therapies for the treatment of cancer patients.
